Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysisLinxuan Wu, Monisha Sharma, Brian Pfau et al.|The Lancet HIV|2024Cited by 26
Cost thresholds for anticipated long‐acting HIV pre‐exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling studyDavid Kaftan, Anna Bershteyn, Monisha Sharma et al.|Journal of the International AIDS Society|2025Cited by 10
Health and budget impact, and price threshold for cost-effectiveness of lenacapavir for PrEP in Eastern and Southern Africa: a modeling analysisLinxuan Wu, Monisha Sharma, Arden L. Saravis et al.|medRxiv|2024Cited by 0
EE446 Health and Budget Impact of Lenacapavir for HIV Pre-Exposure Prophylaxis in South Africa, Western Kenya, and Zimbabwe: A Modeling AnalysisLily Wu, Monisha Sharma, David Kaftan et al.|Value in Health|2024Cited by 0